Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vitamin d may soothe root canal pain, small trial hints

NCT ID NCT07579637

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking vitamin D3 before a root canal can reduce pain afterward. Fifty-four adults with low vitamin D and painful tooth inflammation will receive either a single high dose, a three-day course, or a placebo. Pain levels and painkiller use will be tracked for 48 hours after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vitamin D3 (cholecalciferol) oral capsules
What this could lead to
If it works, this could offer a simple, low-cost way to manage dental pain after root canals, especially for people with low vitamin D.
What could go wrong
This is a small, early-stage trial with only 54 participants, so results may not apply widely. The effect on pain may be modest or no better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Nov 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with serum 25-hydroxyvitamin D level below 30 nmol/L with no vitamin D supplementation for the preceding 3 months. * Patients diagnosed with symptomatic irreversible pulpitis. * Mandibular first molar: Classification of root canal configuration according to Weine's classification: * Distal root: with one portal of exit * Mesial root: Type III, two separate and distinct canals extend from the pulp chamber to the apex. * Patients with moderate to severe pre-operative pain with pain score from 6-10. * Medically free patients with no systemic disease: (American Society of Anesthesiologists / (ASA Class I or II). * The age range is between 20 to 45 years. * Patients have restorable mandibular permanent molars that were diagnosed with symptomatic irreversible pulpitis. * Positive patient's acceptance for participating in the study and signing informed consent Exclusion Criteria: * Patients that have been taking vitamin D supplements in the last 3 months. * Patients with serum 25-hydroxyvitamin D level above 30 nmol/L. * Patients diagnosed with necrosis, partial necrosis, acute or chronic abscess. * Presence of periapical radiolucency. * Patients with systemic conditions that may affect pain perception (e.g., fibromyalgia, diabetes, chronic pain disorders). * Pregnant or lactating females. * Psychologically disturbed patients. * Patients with a history of allergy to any medication used in the study are excluded. * Patients with mild to moderate pain with pain scores less than 6. * Teeth that have: * Periodontally affected molars with grade 2 or 3 mobility. * Non-restorable teeth. * Abnormal anatomy and calcified canals. * Previous root canal treatment. * Patients above 45 years old or below 20 years old. * Non-compliant patients to follow ups. * Patients with very poor oral hygiene.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulpitis - irreversible are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Future University in Egypt

    New Cairo, Select A State Or Province, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.